517 related articles for article (PubMed ID: 1906534)
1. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
[TBL] [Abstract][Full Text] [Related]
2. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
[TBL] [Abstract][Full Text] [Related]
4. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Ohman J; Servo A; Heiskanen O
J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
6. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
[TBL] [Abstract][Full Text] [Related]
7. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
Górski R; Zabek M; Jarmuzek P
Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
[TBL] [Abstract][Full Text] [Related]
8. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm.
Bell TE; Kongable GL
J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759
[TBL] [Abstract][Full Text] [Related]
9. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
Stolke D; Seifert V
Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
[TBL] [Abstract][Full Text] [Related]
10. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
[TBL] [Abstract][Full Text] [Related]
11. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K
Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602
[TBL] [Abstract][Full Text] [Related]
12. Intracisternal rt-PA during early surgery for aneurysmal subarachnoid hemorrhage: an Italian report.
Tomasello F; D'Avella D
J Neurosurg Sci; 1993 Jun; 37(2):71-5. PubMed ID: 8301373
[TBL] [Abstract][Full Text] [Related]
13. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES
J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
[TBL] [Abstract][Full Text] [Related]
16. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
Hall B; Parker D; Carhuapoma JR
Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
Yamamoto T; Esaki T; Nakao Y; Mori K
World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
[TBL] [Abstract][Full Text] [Related]
19. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
Usui M; Saito N; Hoya K; Todo T
Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
[TBL] [Abstract][Full Text] [Related]
20. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
Findlay JM; Jacka MJ
Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
